Patrick Vink, M.D.
Equibles does not estimate personal net worth.
About Patrick Vink, M.D.
Spero Therapeutics, Inc. reported in an 8-K filed June 14, 2023 that Patrick Vink, M.D. was appointed Lead Director of the Board, effective August 1, 2023. Spero Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Spero Therapeutics, Inc. includes Esther Rajavelu (CEO, CFO and Board Member), Ankit Mahadevia, M.D. (Chairman), Frank E. Thomas (Chairman) and 7 others.
“the independent directors of the Board elected Patrick Vink, M.D., a Class II director of the Board, to serve as Lead Director of the Board, effective as of the Transition Date.”
Affiliation history
-
Spero Therapeutics, Inc. (SPRO)
SEC 8-K
Current2023-08-01–present
Company network
Leadership on record at Spero Therapeutics, Inc.
- Esther Rajavelu CEO, CFO, Board Member
- Ankit Mahadevia, M.D. Chairman
- Frank E. Thomas Chairman
- Frank Thomas Chairman
- Stephen J. DiPalma CFO
- Christina Larkin COO
- Tim Keutzer COO
- Timothy Keutzer COO
- Satyavrat Shukla Chief Accounting Officer
- Cynthia Smith Board Member